Trial Profile
A Limited Access Phase II Trial of Weekly Topotecan (NSC 609699), Paclitaxel (NSC 673089), and Cisplatin (NSC 119875) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2009
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary) ; Topotecan (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 05 Mar 2009 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 18 Aug 2006 New trial record.